Ann: Imugene Advances to Phase 2 in Gastric Cancer Trial, page-15

I'm sorry Bevter, but the charts show nothing out of the ordinary for the last few days. My concern is that even this announcement might not be enough to shift them out of this pattern. There's nothing in this announcement that is new, nothing that Leslie hasn't already hinted at. No actual results, some would have been expecting data on how tumours responded or at the very least how much of an increase in antibodies was measured. It's enough to keep me happy with my holding but I reckon there'll be some selling the news going on.